- Home
- SLNH vs TXMD Comparison
SLNH vs TXMD Comparison
Compare SLNH & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- TXMD
- Stock Information
- Founded
- SLNH 1961
- TXMD 2008
- Country
- SLNH United States
- TXMD United States
- Employees
- SLNH N/A
- TXMD N/A
- Industry
- SLNH EDP Services
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- SLNH Technology
- TXMD Health Care
- Exchange
- SLNH Nasdaq
- TXMD Nasdaq
- Market Cap
- SLNH 15.5M
- TXMD 12.7M
- IPO Year
- SLNH N/A
- TXMD N/A
- Fundamental
- Price
- SLNH $0.93
- TXMD $1.08
- Analyst Decision
- SLNH Hold
- TXMD
- Analyst Count
- SLNH 1
- TXMD 0
- Target Price
- SLNH N/A
- TXMD N/A
- AVG Volume (30 Days)
- SLNH 5.2M
- TXMD 16.8K
- Earning Date
- SLNH 11-13-2025
- TXMD 11-11-2025
- Dividend Yield
- SLNH N/A
- TXMD N/A
- EPS Growth
- SLNH N/A
- TXMD N/A
- EPS
- SLNH N/A
- TXMD N/A
- Revenue
- SLNH $27,891,000.00
- TXMD $2,559,000.00
- Revenue This Year
- SLNH N/A
- TXMD $427.09
- Revenue Next Year
- SLNH $32.19
- TXMD N/A
- P/E Ratio
- SLNH N/A
- TXMD N/A
- Revenue Growth
- SLNH N/A
- TXMD 156.93
- 52 Week Low
- SLNH $0.36
- TXMD $0.70
- 52 Week High
- SLNH $4.78
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- SLNH 78.96
- TXMD 44.11
- Support Level
- SLNH $0.43
- TXMD $1.06
- Resistance Level
- SLNH $0.79
- TXMD $1.14
- Average True Range (ATR)
- SLNH 0.08
- TXMD 0.05
- MACD
- SLNH 0.05
- TXMD 0.00
- Stochastic Oscillator
- SLNH 89.29
- TXMD 15.79
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.